Tasly Pharmaceutical Group Co. Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was CNY 9,416.947 million compared to CNY 8,475.946 million a year ago. Operating income was CNY 1,101.684 million compared to CNY 1,148.078 million a year ago. Net income was CNY 898.503 million compared to CNY 925.001 million a year ago. Basic earnings per share from continuing operations was CNY 0.5957 compared to CNY 0.6115 a year ago.